Evidence map›Paper›PMID 37958994›Full record

ArticleInternational journal of molecular sciences2023

Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells.

Yasuyuki Akasaka, Shun Hasei, Yukino Ohata, Machi Kanna, Yusuke Nakatsu, Hideyuki Sakoda, Midori Fujishiro, Akifumi Kushiyama, Hiraku Ono, Akio Matsubara and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Yasuyuki AkasakaDepartment of Biomedical Chemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.
Shun HaseiDepartment of Biomedical Chemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.
Yukino OhataDepartment of Biomedical Chemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.
Machi KannaDepartment of Biomedical Chemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.
Yusuke NakatsuDepartment of Biomedical Chemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.
Hideyuki SakodaDepartment of Bioregulatory Sciences, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, Japan.
Midori FujishiroDivision of Diabetes and Metabolic Diseases, Nihon University School of Medicine, Tokyo 173-8610, Japan.
Akifumi KushiyamaDepartment of Pharmacotherapy, Meiji Pharmaceutical University, Kiyose 204-8588, Japan.ORCID 0000-0003-1385-7487
Hiraku OnoDepartment of Clinical Cell Biology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Akio MatsubaraDepartment of Urology, JA Hiroshima General Hospital, Hatsukaichi 738-8503, Japan.
Nobuyuki HinataDepartment of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.ORCID 0000-0001-7014-6812
Tomoichiro AsanoDepartment of Biomedical Chemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.
Takeshi YamamotoyaDepartment of Biomedical Chemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.
Hiroshima University · JPChiba University · JPHiroshima General Hospital · JPMeiji Pharmaceutical University · JPNihon University · JPUniversity of Miyazaki · JP

Funding

Japan Society for the Promotion of Science 20H03732Japan Society for the Promotion of Science 21K08580Japan Society for the Promotion of Science 23H02959
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AMP-Activated Protein KinasesProstatic NeoplasmsAMP-Activated Protein Kinase KinasesCell Line, TumorCell ProliferationCoumarinsHEK293 CellsHumansMalePhosphorylationProstateProstate-Specific AntigenProtein Serine-Threonine KinasesReceptors, AndrogenTOR Serine-Threonine KinasesAMP-Activated Protein Kinase KinasesAMP-Activated Protein KinasesauraptenCoumarinsProstate-Specific AntigenProtein Serine-Threonine KinasesReceptors, AndrogenTOR Serine-Threonine KinasesAMPKandrogen receptoraurapteneLKB1prostate cancerprostate-specific antigen

Identifiers

PMID37958994
PMCPMC10650886
OpenAlexW4388445188

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.